| RS2143963488 |
RAD51C
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group O, Fanconi anemia complementation group O |
| RS2143965549 |
FAM20A
|
Health Risk |
Pathogenic |
Amelogenesis imperfecta type 1G, Amelogenesis imperfecta type 1G |
| RS2143966219 |
KAT8
|
Health Risk |
Pathogenic |
Li-Ghorbani-Weisz-Hubshman syndrome, Li-Ghorbani-Weisz-Hubshman syndrome |
| RS2143966223 |
MC4R
|
Health Risk |
Pathogenic |
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20, BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20 |
| RS2143966454 |
KAT8
|
Health Risk |
Pathogenic |
— |
| RS2143966828 |
MC4R
|
Health Risk |
Pathogenic/Likely pathogenic |
MC4R-related disorder, Obesity due to melanocortin 4 receptor deficiency |
| RS2143967167 |
MC4R
|
Health Risk |
Pathogenic |
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20, MC4R-related disorder |
| RS2143967182 |
MC4R
|
Health Risk |
Likely pathogenic |
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20, BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20 |
| RS2143969631 |
LAMA1
|
Health Risk |
Likely pathogenic |
Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome, Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome |
| RS2143971140 |
NAGS
|
Health Risk |
Likely pathogenic |
Hyperammonemia, type III |
| RS2143974313 |
LOXHD1
|
Health Risk |
Pathogenic |
— |
| RS2143975211 |
RGS9
|
Health Risk |
Likely pathogenic |
— |
| RS2143975765 |
CDH2
|
Health Risk |
Pathogenic/Likely pathogenic |
Arrhythmogenic right ventricular dysplasia, familial |
| RS2143975890 |
LAMA1
|
Health Risk |
Likely pathogenic |
— |
| RS2143975906 |
LOXHD1
|
Health Risk |
Pathogenic |
— |
| RS2143978288 |
NAGS
|
Health Risk |
Pathogenic |
Hyperammonemia, type III |
| RS2143978561 |
NAGS
|
Health Risk |
Pathogenic |
Hyperammonemia, type III |
| RS2143978628 |
NAGS
|
Health Risk |
Pathogenic |
Hyperammonemia, type III |
| RS2143978844 |
NAGS
|
Health Risk |
Pathogenic |
Hyperammonemia, type III |
| RS2143980093 |
NAGS
|
Health Risk |
Pathogenic |
Hyperammonemia, type III |
| RS2143980228 |
NAGS
|
Health Risk |
Pathogenic |
Hyperammonemia, type III |
| RS2143980289 |
SMARCE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial meningioma, Hereditary cancer-predisposing syndrome |
| RS2143980805 |
SMARCE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial meningioma, Hereditary cancer-predisposing syndrome |
| RS2143984711 |
NAGS
|
Health Risk |
Pathogenic |
Hyperammonemia, type III |
| RS2143984936 |
SMARCE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial meningioma, Hereditary cancer-predisposing syndrome |
| RS2143985147 |
SMARCE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial meningioma, Hereditary cancer-predisposing syndrome |
| RS2143985266 |
SMARCE1
|
Health Risk |
Likely pathogenic |
Familial meningioma, Familial meningioma |
| RS2143985614 |
KAT8
|
Health Risk |
Likely pathogenic |
Li-Ghorbani-Weisz-Hubshman syndrome, Li-Ghorbani-Weisz-Hubshman syndrome |
| RS2143985704 |
NAGS
|
Health Risk |
Pathogenic |
Hyperammonemia, type III |
| RS2143986114 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2143986336 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2143986529 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS2143986669 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS2143986707 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2143986751 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2143986798 |
SMARCE1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2143986835 |
SMARCE1
|
Health Risk |
Pathogenic |
Familial meningioma, Familial meningioma |
| RS2143986851 |
SMARCE1
|
Health Risk |
Pathogenic |
Familial meningioma, Familial meningioma |
| RS2143987192 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2143987317 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2143987485 |
WNK4
|
Health Risk |
Pathogenic |
Pseudohypoaldosteronism type 2B, Pseudohypoaldosteronism type 2B |
| RS2143988221 |
SMARCE1
|
Health Risk |
Likely pathogenic |
Familial meningioma, Familial meningioma |
| RS2143988272 |
SMARCE1
|
Health Risk |
Pathogenic |
Familial meningioma, Familial meningioma |
| RS2143988301 |
SMARCE1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial meningioma |
| RS2143988635 |
SMARCE1
|
Health Risk |
Likely pathogenic |
Familial meningioma, Familial meningioma |
| RS2143989504 |
NAGS
|
Health Risk |
Likely pathogenic |
Hyperammonemia, type III |
| RS2143989613 |
NAGS
|
Health Risk |
Likely pathogenic |
Hyperammonemia, type III |
| RS2143989730 |
NAGS
|
Health Risk |
Likely pathogenic |
Hyperammonemia, type III |
| RS2143991359 |
NAGS
|
Health Risk |
Likely pathogenic |
Hyperammonemia, type III |
| RS2143992779 |
RGS9
|
Health Risk |
Pathogenic |
— |
| RS2143996133 |
SMARCE1
|
Health Risk |
Pathogenic |
Familial meningioma, Hereditary cancer-predisposing syndrome |
| RS2143996366 |
SMARCE1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial meningioma |
| RS2143997220 |
SMARCE1
|
Health Risk |
Likely pathogenic |
Familial meningioma, Familial meningioma |
| RS2143997316 |
SMARCE1
|
Health Risk |
Pathogenic |
Familial meningioma, Hereditary cancer-predisposing syndrome |
| RS2143997365 |
SMARCE1
|
Health Risk |
Pathogenic |
Tessier cleft, Medulloblastoma non-WNT/non-SHH group 3 |
| RS2143997384 |
SMARCE1
|
Health Risk |
Likely pathogenic |
Familial meningioma, Familial meningioma |
| RS2143997424 |
SMARCE1
|
Health Risk |
Likely pathogenic |
— |
| RS2143999488 |
LAMA1
|
Health Risk |
Pathogenic |
— |
| RS2144002229 |
LOXHD1
|
Health Risk |
Likely pathogenic |
— |
| RS2144002337 |
PIEZO2
|
Health Risk |
Pathogenic |
Arthrogryposis- oculomotor limitation-electroretinal anomalies syndrome, Arthrogryposis- oculomotor limitation-electroretinal anomalies syndrome |
| RS2144002934 |
PIEZO2
|
Health Risk |
Pathogenic |
— |
| RS2144003305 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS2144003808 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2144003884 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2144003901 |
NF1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS2144003933 |
LOXHD1
|
Health Risk |
Pathogenic |
— |
| RS2144003956 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2144003986 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2144004029 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2144004136 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2144004304 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2144004331 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2144004346 |
NF1
|
Health Risk |
Pathogenic |
— |
| RS2144004523 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2144004547 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS2144004677 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2144004751 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2144004838 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2144005065 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS2144009190 |
SMARCE1
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial meningioma, Familial meningioma |
| RS2144009228 |
SMARCE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial meningioma, Hereditary cancer-predisposing syndrome |
| RS2144013371 |
LOXHD1
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 77, Autosomal recessive nonsyndromic hearing loss 77 |
| RS2144015153 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS2144015428 |
LOXHD1
|
Health Risk |
Pathogenic |
— |
| RS2144015494 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS2144015567 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2144015630 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2144015861 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2144015942 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2144015956 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2144016093 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2144016379 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2144016542 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2144016775 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2144016788 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2144016800 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2144017227 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2144018381 |
LAMA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome, Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome |
| RS2144018707 |
FOXC2
|
Health Risk |
Pathogenic |
Distichiasis-lymphedema syndrome, Distichiasis-lymphedema syndrome |
| RS2144019324 |
FOXC2
|
Health Risk |
Pathogenic |
Distichiasis-lymphedema syndrome, Distichiasis-lymphedema syndrome |